StockData
COMPASS Pathways plc logo

COMPASS Pathways plc (CMPS) stock

CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 1/30
$9.12−0.18 (-1.94%)

Close on Nov 12, 2026Market cap $1.26BP/E –Yield –

Earnings

COMPASS Pathways's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.31
-$1.44 a year earlier
Latest guidance
Issued
Nov 4, 2025 · 1 item

Quarterly results

Revenue and earnings per share from each of COMPASS Pathways's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 23, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 3, 2026before the open––-$0.31Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026before the open––-$1.88Release
Q1 FY2026ended Mar 31, 2026May 13, 2026before the open––-$0.30Release
Q4 FY2025ended Dec 31, 2025Mar 24, 2026before the open––-$1.00Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025before the open––-$1.44Release
Q2 FY2025ended Jun 30, 2025Jul 31, 2025before the open––-$0.41Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025before the open––-$0.63Release
Q3 FY2024ended Sep 30, 2024Oct 31, 2024before the open––-$0.56Release
Q2 FY2024ended Jun 30, 2024Aug 1, 2024before the open––-$0.56Release
Q1 FY2024ended Mar 31, 2024May 8, 2024before the open––-$0.55Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period COMPASS Pathways guided for has been reported

Guidance history

Every forecast COMPASS Pathways put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2025net cash used in operating activitiesFY2025$120.00M – $145.00MNew
Jul 31, 2025net cash used in operating activitiesFY2025$120.00M – $145.00MNew
May 8, 2025net cash used in operating activitiesFY2025$120.00M – $145.00MReaffirmed
Feb 27, 2025net cash used in operating activitiesFY2025$120.00M – $145.00MNew
Oct 31, 2024net cash used in operating activitiesQ4 FY2024$37.00M – $43.00MNew
Oct 31, 2024net cash used in operating activitiesFY2024$114.00M – $120.00MNarrowed
Aug 1, 2024net cash used in operating activitiesQ3 FY2024$32.00M – $38.00MNew
Aug 1, 2024net cash used in operating activitiesFY2024$110.00M – $130.00MReaffirmed
May 8, 2024net cash used in operating activitiesQ2 FY2024$32.00M – $38.00MNew
May 8, 2024net cash used in operating activitiesFY2024$110.00M – $130.00MReaffirmed
Feb 29, 2024net cash used in operating activitiesQ1 FY2024$17.00M – $23.00MNew
Feb 29, 2024net cash used in operating activitiesFY2024$110.00M – $130.00MNew
Nov 2, 2023net cash used in operating activitiesQ4 FY2023$9.00M – $15.00MNew
Nov 2, 2023net cash used in operating activitiesFY2023$79.00M – $85.00MLowered
Aug 3, 2023net cash (provided by)/used in operating activitiesQ3 FY2023-$2.00M – $18.00MNew
Aug 3, 2023net cash used in operating activitiesFY2023$80.00M – $90.00MLowered
May 11, 2023net cash used in operating activitiesQ2 FY2023$22.00M – $30.00MNew
May 11, 2023net cash used in operating activitiesFY2023$85.00M – $110.00MReaffirmed
Feb 28, 2023net cash used in operating activitiesQ1 FY2023$24.00M – $32.00MNew
Feb 28, 2023net cash used in operating activitiesFY2023$85.00M – $110.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases COMPASS Pathways filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Results
  6. Update
  7. Update
  8. Results
  9. Results
  10. Results
  11. Results
  12. Update
  13. Results
  14. Results
  15. Results

See a number that looks wrong?